Sdi Share Discussion Threads

[gnnmartin] 07/11/2014 13:49

I have attended the last 2 AGMs, but what I say here is my impression, rather than what I was explicitly told. I think a lot has been spent re-engineering the products, but it remains to be seen whether the re-engineering was aimed at pleasing a particular customer, and if so, whether it significantly enhances the product in the eyes of other potential customers. In other words, the as yet to be determined question is whether the re-engineering ought strictly to be accounted for as a cost of sale, or whether it is reasonable to capitalise at least a part of it.

I can't answer that, but the lack of progress on profits suggests a discouraging answer. I bought in hoping that ProReveal would be a winner. It may yet be.

I continue to hold the shares, but they are not top of my list to accumulate.
Nigel Martin

[mudbath] 06/11/2014 19:34

Bakunin.
I took an interest in SDI as a result of my respect for the thread instigator Nick2008.He does not post much, yet seems pretty knowledgeable,with his successes including AtukUK (now CloudBuy) @ 5 pence against the current 45..
Otherwise I am self taught on matters Scientific.
There are precious few (if any) bullish posters here,so if you find a reason for optimism,do let us know.

[mudbath] 06/11/2014 15:00

Hello Bakunin !
I have spent much time getting the feel of SDI and so appreciate the thrust of your posting.
It is a nuance thing really.
For example,whilst you are correct as regards the treatment of capitalised development expenditure,where amortisation is due to occur over three years;it is the level of those last year costs which I would regard as exceptional,thus leading to lower A&D over future years.My reasoning here being that the past two years have been ones of enhancing and redefining the whole product range resulting in the aforementioned costs running some £200k above the norm.
Similarly with adverse currency influences,rationalisation/acquisition costs,and finance charges; I would anticipate these having a diminishing impact over coming reporting periods.
As regards revenues,I believe that the increasing range of offerings and its revised pricing,added to new innovative products developed both in house and via the Opus investment should see a marked uplift in sales.
Almost every paragraph of the annual report suggests that there is more than a degree of optimism regarding current and future prospects.

Whilst the BOD have often opined that they believe SDI has the products to meet market requirements,to my knowledge this is the first time they have espied "success".

"The Board has a positive view for success in the current financial year."

As stated,the shares in SDI are illiquid.If bought judiciously around current levels then I would confidently expect to see the value of any such investment double at worst over the coming 12 months.

I could of course be wrong,yet such is my strong opinion.

[mudbath] 06/11/2014 09:22

"The Board has a positive view for success in the current financial year."

At just 11 pence,I have an exceptionally positive view on the trend of the share price over the next twelve months.

Strip out the kitchen sink exceptionals from last years figures and the potential for an eye watering turnaround from loss to significant profitability emerges.

Illiquidity has forced the share price down to its current ludicrously low level as a trickle of investors have ditched their holdings in an unwilling market.

A sharp upward reversal lies ahead as SDI prepares to present its interim accounts in December.

Imo.

[bookbroker] 04/11/2014 12:58

That's the least we should come to expect, a very disappointing performance thus far by this co., a lot of talk from management, they now need to walk the walk, otherwise they should be whipped!

[mudbath] 04/11/2014 12:46

Last year was one of (costly)transformation for Scientific,with a full refresh of the product range allied to a repricing, plus an extended range for the new distribution network to get its teeth into.Add to this the investment by SDI in Opus Instruments with its potentially complimentary technologies and we have the potential for quite a turnaround in SDI's fortunes.
The y/e April 2014 figures were particularly dampened by the exceptionally high(non cash) depreciation and amortisation figures which totaled £595,000.
For a company with a market cap of just £3.06 million,these distortions have temporarily taken an unjustified toll on the share price.
Massively cheap then at the current 10-12 pence quote.
A (likely)significant uplift in revenues and profitability through the current year should see the current share price doubling(conservatively).
IMO

[wormhasturned] 21/10/2014 12:11

Ken Ford needs to go, so far he has failed shareholders miserably with his projections, holders are facing large losses due too his total incompetence, he should do the honourable thing and accept that he is not up to the job!

[adamb1978] 31/5/2014 14:35

Glad I sold this in April! Cant see that, absent any new news, this becomes interesting until it gets down to about 12p

[hastings] 20/5/2014 17:36

Thoughts may be of interesthttp://www.privatepunter.co.uk/News/news-20-may-2014

[bookbroker] 20/5/2014 09:17

Ford sounds like a fanny merchant, holding these but he never seems to be able to meet expectations, needs to go, SDI needs a CE. who is able to deliver. Shareholders have suffered enough!

[nick2008] 15/5/2014 12:29

Artemis CCD Ltd Announces New Distribution http://www.biospace.com/News/artemis-ccd-ltd-announces-new-distribution-partner/333420Artemis CCD Ltd Announces New Distribution Partner5/13/2014 8:39:48 AM Norwich, UK: Artemis CCD Limited, a leading manufacturer of cooled CCD cameras for low-light applications, today announces a partnership with G4 Technology Co. Ltd for the distribution of cooled CCD cameras in the territories of The Republic of China and Taiwan. The agreement covers the complete range of Artemis CCD Cameras® and represents a significant expansion of the global partner programme specialising in sales to science and industrial business customers. Offering exceptional performance in long exposure imaging, the range of products from Artemis CCD has a proven track record in low light applications such as fluorescence and chemi-luminescence imaging and more recently electroluminescence testing of photovoltaic solar cells and panels. The appointment of G4 is a significant step in the business development plans for this rapidly expanding UK company. Chris Andrews, Artemis CCD's Sales and Marketing Manager said: "This is a very important element in our developing supply chain for the Artemis CCD camera range in major markets around the world. For our customers, the benefit of a trusted local partner is vital to support sales to end users in addition to our direct OEM business. The team at G4 has impressed us considerably with their range of complementary products and application knowledge. We are very excited by the opportunities our relationship will bring." Ken Chou, Sales Manager of G4 Technology Co. Ltd said: "G4 has many years of experience in the field of industrial image processing with a wide range of components and solutions. We continually search for new technology to satisfy critical applications. We are very glad to cooperate with Artemis CCD. Artemis CCD Cameras complete our product line up for the scientific community and others requiring low noise imaging in low light applications. With this agreement, we believe more new opportunities will be created" For Further Information Contact:Chris Andrews, Sales & Marketing Manager Artemis CCD Limited 8 Lodge Farm Barns New Road, Bawburgh, Norwich, NR9 3LZ, UK.Tel: [phone]Fax: [phone]Email: [e-mail]: www:artemisccd.com About Artemis-CCDArtemis CCD is a leading manufacturer of cooled low-light application cameras for the scientific and industrial sectors. Artemis CCD's camera ranges are integrated into spectroscopy equipment, microscopy, gel documentation and chemi-luminescent imaging systems and are successfully delivering results in many of the world's top life science companies and major research institutes. Artemis CCD was founded in 2000 and is now a wholly owned subsidiary of Scientific Digital Imaging plc headquartered in Cambridge, UK. The company has an Operations and R&D facility based in Norwich, UK and a Manufacturing base in a dedicated factory in Lisbon, Portugal.About G4 Technology Co. LtdG4 was founded on Oct. 1st, 2001 by the most diverse and professional team who have many years of experience endowing machines with 'vision'. While gaining a fast growing market share, G4 is expecting to become the largest Asia provider of components in the industrial image processing sector. G4 offers our customer optimum support and powerful products. We embody customer-oriented, solution-oriented and reliable competence in the industrial image processing sector. We are your reliable image processing partner with the most comprehensive range of products and support services in Asia. www.g4.com.tw/web/english.

[adamb1978] 10/4/2014 08:16

Sold my very small holding in these as well over the last couple weeks.

Main reason being that when I looked at what I thought might play out over H2 and then drive the full year figures, I didn't think it looked that great.

Lets assuming that H2 turnover rises 3% year on year from their very strong H2 last year, that's a 14% rise half of half in FY14 - there very much in line with the comments at the interims re performance being second half weighted.

Even with that assumptions, I get EPS of about 1.1p so a PE of around 19x. Given that that will only be EPS growth of about 9% based on my figures, I cant see Mr Market saying that paying 19x for a sub-10% growth company is right, let along cheap.

Could see myself buying back into these if the share prices drops to mid-teens but I just don't see any upside from current levels over the next year. I just cant see how it will re-rate to say 25x current year.

I COULD however see upside if they deliver 1.1p EPS this year and then the next interims give shareholders confidence that they can deliver 5%-10% top line growth in 2015 as, with the operational gearing, that might mean they deliver 2p EPS in 2015 and then this starts to look cheap. However turnover was £7.2m in 2010 and in 2014 it looks like it might be only around £7.5m so I don't think people will naturally give management the benefit of the doubt that they can grow this - this need to actually achieve some growth

Adam

[pugugly] 10/4/2014 07:49

BP Pension fund selling down - Initial take NEGATIVE. Message received the Investment Management of the pension fund have concluded that growth and profit will not meet their objectives.

[bookbroker] 17/3/2014 12:33

Let's hope those stunning broadcasts from the Space Station last night might enthuse a legion of stargazers into acquiring some of these fancy optics this co. produces!

[nick2008] 14/3/2014 07:51

News this morning - Scientific Digital Imaging Plc Expansion of Imaging Systems rangeTIDMSDIScientific Digital Imaging Plc14 March 2014SCIENTIFIC DIGITAL IMAGING PLCScientific Digital Imaging Expands its Range of Imaging Systemsfor Fast, Accurate Imaging of 2D or 1D Gels and all Blot TypesCambridge, UK: Scientific Digital Imaging (AIM: SDI, "SDI" or the "Company"), the AIM quoted group focused on the application of digital imaging technology to the needs of the scientific community, has introduced their new high sensitivity G:BOX Chemi XX6 and XX9 image analysis systems. Utilizing the power of the latest CCD camera technology, these systems are suitable for scientists needing a versatile system capable of exceptional imaging of 1D and 2D gels, as well as chemi and fluorescent blots.The G:BOX Chemi XX6 and XX9 feature high resolution, high quantum efficiency (73% quantum efficiency at 425nm) low noise CCD cameras with the highest level (f0.95) auto-focus lens and 6 and 9 megapixel resolution respectively. Since the cameras are cooled to -53(o) C, the XX9 and XX6 systems can generate excellent images of chemi blots with minimal background noise and the system's large imaging areas (32.3cm x 25.6cm) also mean both systems are ideal for those scientists wanting to accurately image larger blots, as well as larger 1D and 2D gels.This new generation of G:BOX Chemi XX systems are designed for researchers looking for high performance imaging, as they can be fitted with a range of LED lighting and filter options making them suitable for fluorescence, chemiluminescence, IR and 2D gel applications. With the new G:BOX Chemi XX6 and XX9, scientists can work with an automated multiplexed function capable of using up to five channels, as well as an edge lighting option for 2D gel capture including DIGE gels. This versatility ensures scientists have a cost-effective imaging system that can generate accurate results from a diverse range of gel and blot types.Images are captured by the G:BOX Chemi XX systems using the powerful GeneSys image capture software, which selects optimal filter/lighting combinations by utilising its database containing imaging conditions for hundreds of commercially available dyes. Researchers then select their preferred protocol and the G:BOX Chemi XX automatically captures a high-quality image of the different dyes. For even faster, automated image capture, GeneSys includes a researcher 'protocol save' feature enabling one-click recall of frequently used imaging settings.Laura Sullivan, Divisional Manager of SDI's subsidiary Syngene, explained: "In proteomics labs and core facilities, scientists need image analysers which are capable of accurately imaging large 2D protein gels, as well as easily generating images of multiplex chemi and fluorescent blots. This requires extremely sensitive, low-noise cameras and sophisticated, yet simple to use software to set up the optimum imaging conditions."Laura concluded: "We have listened to these challenging requests and are pleased to have successfully developed our two new G:BOX Chemi systems to meet them. The combination of our latest high quantum efficiency, low-noise cameras and upgraded GeneSys image capture software means that the G:BOX Chemi XX6 and XX9 will deliver fast, high quality results which will delight scientists in any proteomics labs using these image analysers."-Ends-For Further Information Contact:Scientific Digital Imaging:Mike Creedon, Chief Executive of SDI - 01223 727144finnCapEd Frisby / Ben Thompson, corporate finance - 020 7220 0500Simon Starr, corporate brokingJW CommunicationsJulia Wilson, Investor & Public Relations - 0781 8430877Note to EditorsAbout Scientific Digital Imaging plcScientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. Within Synoptics, the recently formed Synoptics Health division has launched the Synoptics Health ProReveal system. This patented system offers a highly sensitive fluorescence-based test to detect dirty surgical instruments in hospitals and aims to reduce incidences of cross contamination of patients. In addition, under the Atik brand, SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications. www.scientificdigitalimaging.comThis information is provided by RNSThe company news service from the London Stock ExchangeENDNRASFLFWDFLSEED

[adamb1978] 05/3/2014 18:30

Think the Silverdell mention is a cheap shot - not much a broker can do if a company turns out to have lied to them as well as the market

[fillipe] 05/3/2014 10:52

Thaanks, I'll do that!

f

[bookbroker] 05/3/2014 09:40

Not sure if I would trust Finncap, after the Silverdell debacle one ought to take anything they state with a pinch of salt!

[fillipe] 05/3/2014 09:33

The shares are much too lowly priced at the present time.

House broker, FinnCap 03/03/2014 CORP.
2014 eps 3.80p
2015 eps 4.00p

Year ends are 30th April, so not long to go.

I wouldn't be surprised to see a 50p tp here if the 2014 numbers above are confirmed.

f

[mudbath] 05/3/2014 08:40

bookbroker.
I feel confident that the SDI share price will soon surpass that recent high at which you wished you had sold.
Stick with these for a rewarding couple of years imo.

[bookbroker] 28/2/2014 09:55

Not are why this co. on the acquisition trail, haven't they got enough on their plate trying to eke out profits from existing businesses, looks to me a defensive move, share price telling us that here is another co. that management seem to be looking after themselves rather than shareholders.